Effects of silver nanoparticles on the liver and hepatocytes in vitro.

@article{Gaiser2013EffectsOS,
  title={Effects of silver nanoparticles on the liver and hepatocytes in vitro.},
  author={Birgit K Gaiser and Stephanie Hirn and Ali Kermanizadeh and Nilesh Kanase and Kleanthis Fytianos and Alexander Wenk and Nadine Haberl and Andrea Brunelli and Wolfgang G. Kreyling and Vicki Stone},
  journal={Toxicological sciences : an official journal of the Society of Toxicology},
  year={2013},
  volume={131 2},
  pages={
          537-47
        }
}
  • B. Gaiser, Stephanie Hirn, +7 authors V. Stone
  • Published 1 February 2013
  • Biology, Medicine
  • Toxicological sciences : an official journal of the Society of Toxicology
With the increasing use and incorporation of nanoparticles (NPs) into consumer products, screening for potential toxicity is necessary to ensure customer safety. NPs have been shown to translocate to the bloodstream following inhalation and ingestion, and such studies demonstrate that the liver is an important organ for accumulation. Silver (Ag) NPs are highly relevant for human exposure due to their use in food contact materials, dietary supplements, and antibacterial wound treatments. Due to… 
The role of Kupffer cells in the hepatic response to silver nanoparticles
TLDR
This study investigates the effect of a silver NP on the liver, and in particular, the role of Kupffer cells (KCs; resident liver macrophages) in the overall inflammatory response in the organ and suggests that tolerance to the Ag NPs is favoured over a fully activated immune response.
Acute hazard assessment of silver nanoparticles following intratracheal instillation, oral and intravenous injection exposures
TLDR
The data clearly demonstrated that bioaccumulation and toxicity of the particles were most significant following the IV route of exposure, followed by IT, however, oral exposure to the NPs did not result in any changes that could be interpreted as toxicity in any of the organs of interest within the confines of this investigation.
A review on silver nanoparticles-induced ecotoxicity and the underlying toxicity mechanisms.
Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture
TLDR
The results suggest that cellular oxidative stress did not play a major role in the observed cytotoxicity of nanosilver in HepG2 and Caco2 cells and that a different mechanism of nanOSilver‐induced mitochondrial injury leads to the cytot toxicity.
In vitro toxicological screening of nanoparticles on primary human endothelial cells and the role of flow in modulating cell response
TLDR
It is necessary to develop more physiologically relevant in vitro models to better understand how nanomaterials can impact on human health, and although simple in vitro tests are useful to screen compounds, they may not be sufficient to define safe exposure limits.
Comparison of in vitro toxicity of silver ions and silver nanoparticles on human hepatoma cells
TLDR
Treatment with either AgNP or Ag ions resulted in membrane damage and reduced the cell function of human liver cells, and oxidative stress markers indicated that oxidative stress might contribute to the toxicity effects of nano and ionic forms of silver.
Toxicological effect of engineered nanomaterials on the liver
TLDR
The overall aim of this review is to outline what data is available in the literature for the toxicity elicited by NMs to the liver in order to establish a weight of evidence approach (for risk assessors) to inform on the potential hazards posed by N Ms to the Liver.
Health Impact of Silver Nanoparticles: A Review of the Biodistribution and Toxicity Following Various Routes of Exposure
TLDR
The present review discusses the current advances on the physiochemical properties of AgNPs with specific emphasis on biodistribution and both in vitro and in vivo toxicity following various routes of exposure.
Pharmacokinetics of metallic nanoparticles.
TLDR
Physiologically based pharmacokinetic models for gold/dendrimer composite nanodevices, AgNPs, and TiO2 NP models have been developed in rats and extrapolated to humans to support risk assessment and nanomedicine applications.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
Interspecies comparisons on the uptake and toxicity of silver and cerium dioxide nanoparticles.
TLDR
The commonalities in toxicity of these particle types across diverse biological systems suggest that cross-species extrapolations may be possible for metal nanoparticle test development in the future and suggest transport of particles through the gastrointestinal barrier is likely to be an important uptake route when assessing particle risk.
A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity
This review is concerned with evaluating the toxicity associated with human exposure to silver and gold nanoparticles (NPs), due to the relative abundance of toxicity data available for these
Development of in vitro systems for nanotoxicology: methodological considerations
TLDR
Some of the most frequently used assays to assess the cytotoxity and biological reactivity of nanoparticles in vitro, ranging from simple cytotoxicity assays, to measurement of reactive oxygen species and oxidative stress, activation of proinflammatory signaling, and finally genotoxicity are outlined.
In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers
Abstract Effects on the liver C3A cell line treated with a panel of engineered nanomaterials (NMs) consisting of two zinc oxide particles (ZnO; coated 100 nm and uncoated 130 nm), two multi-walled
Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract.
TLDR
Two important themes of current research into the effects of NSP on the lungs are reviewed: The potential of Nsp to cross the blood-air barrier of the lungs, thus gaining access to the circulation and extrapulmonary organs and the entering mechanisms of N SP into different cell types.
Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: Comparison with conventional monocultures
TLDR
Evidence is presented that the in vitro coculture model of the alveolar-capillary barrier is clearly advantageous compared to conventional monocultures in evaluating the extent of damage caused by hazardous material encountering the principle biological barrier in the lower respiratory tract.
Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration
TLDR
The highest accumulation in secondary organs was mostly found for 1.4 nm particles; the negatively charged particles were accumulated mostly more than positively charged particles, and 18 nm particles show a higher accumulation in brain and heart compared to other sized particles.
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
  • A. Alkilany, C. Murphy
  • Biology, Chemistry
    Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology
  • 2010
TLDR
Recent results that address the toxicity of gold nanoparticles both in vitro and in vivo are discussed, and some experimental recommendations for future research at the interface of nanotechnology and biological systems are provided.
Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: Role of ROS-NFκB signaling pathway
TLDR
Investigating the inflammatory responses of mouse macrophages exposed to nanoparticles reveals that Ag NPs exhibit higher propensity in inducing inflammation, mediated by ROS and NF-κB signaling pathways and leading to the induction of COX-2, TNF-α and IL-6, however, no such prominent pro-inflammatory responses were observed with Au NPs, suggesting their bio-compatibility.
...
1
2
3
4
5
...